Answers are grounded in this paper and cite their sources.
Selumetinib has promising antitumor activity in children with LGG. Rash and mucositis were the most common DLTs.
No takes yet. Share an insight, caveat, or question.
Banerjee et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: